Skill Management Approaches with RCR and TMC-K in Clinical Oncology

1st Joint Clinical Oncology Conference of Royal College of Radiologists, London and Tata Medical Center, Kolkata

Prof. Tom Crosby, Velindre Cancer Centre, Cardiff, United Kingdom

Tom is a Consultant Oncologist in Velindre Cancer Centre, specialising in Upper GI cancer since 2008.

As clinical lead for the Wales Cancer Network Tom lead the development of the Cancer Delivery Plan 2016-20, Peer Review of Cancer Services in Wales and the Cancer Implementation Group’s prioritisation programme including the development of Cancer Prevention, Early Diagnosis, Person Centred Care and Cancer Information Subgroups. He is also helping to lead the development a new Cancer Research Strategy for Wales. He currently leads a priority initiative in Wales: the Single Cancer Pathway which looks to transform patient pathways from referral, through diagnosis to treatment.

Tom is a leader in Upper GI Oesophageal Chemo-radiotherapy Research, Service and Development in the UK. He is Chief Investigator to the series of UK Multi-centre SCOPE trials (SCOPE1, NeoSCOPE and SCOPE2). He is currently Chair of the NCRI OG Cancer Subgroup and co-lead applicant on the ambitious stratified medicine programme in oesophageal cancer known as Oelixir.

He was Lead of the inaugural RCR Site Oriented e-Network and is the current Welsh and Oncology Lead for the UK National Oesophago-Gastric Cancer Audit.

Tom has been an examiner for the Royal College Radiologists Part 2 Exam and is the Chair of the Cardiff FRCR 2 Course a lead author of the textbook Practical Clinical Oncology (Cambridge University Press).

Tom is currently the clinical lead for the Transformation of Cancer Services Programme in South East Wales. This ambitious programme will seek to develop a new world class Velindre Cancer Centre and redesign the clinical service model to meet the demands of future care and improve outcomes for patients.

Tom has recently been recognised for his service to cancer services in Wales and the UK with the award of an honorary Professorship by Cardiff University and an OBE in the New Year’s Honours list and is now the National Clinical Director of Cancer for Wales.

Dr. Derek Grose, Beatson West of Scotland Cancer Centre , United Kingdom

Derek is a Consultant Clinical Oncologist + Honorary Senior Lecturer at the Beatson West of Scotland Cancer Centre since Jan 2011 with sub speciality interests in Upper GI and Head/Neck. His main research interests are in technical radiotherapy in Upper GI malignancy and systemic therapy trials in Head/Neck cancers. He chairs the North Glasgow Head/Neck MDT and is deputy lead for the West of Scotland Head/Neck MCN. He is the clinical lead for the regional oligometastatic SABR service

He has a number of current research grants including the development of autosegmentation software to aid target definition in head/neck cancer radiotherapy planning with MRI and a recently awarded Pancreatic Cancer UK (PCUK) grant to explore the correlation of hypoxic imaging, using PET Fluromisonidazole (F-MISO), with pathological specimens in patients undergoing neoadjuvant (chemo) radiotherapy for borderline resectable pancreatic cancer.

He is the Clinical Chief Investigator for the PRIMUS 002 trial focusing on biomarker and liquid biopsy development in the neoadjuvant setting in Pancreatic Cancer. This study is one of the first two in the PRECISION-PANC platform. He is PI for a number of previous and ongoing trials of systemic therapy in head/neck cancer which has lead to extensive experience with novel agents including Immuno-Oncology therapy in this setting.

Dr. Ganesh Radhakrishnan, Christie Hospital, Manchester, United Kingdom


Dr. Reena Engineer, Tata Memorial Hospital, Mumbai


Dr. Kaustav Talapatra, Kokilaben Dhirubhai Ambani Hospital, Mumbai


Dr. Indranil Mallick, Tata Medical Center, Kolkata